S100A10 and ovarian cancer: S100A10 is an oncogenic event in various malignancies, including thyroid anaplastic carcinoma, colorectal cancer and ovarian cancer (Ito et al., 2007; Suzuki and Tanigawara, 2014; Lokman et al., 2016).